Commentary
See article on page 364Beyond acid suppressants in gastro-oesophageal reflux disease
| The first 150 words of the full text of this article appear below. |
The burden of gastro-oesophageal reflux disease becomes apparent when one considers that treatment with acid suppressants accounts for a significant proportion of our national healthcare budget.1 Oh et al present evidence in this issue of Gut2 that a novel antioxidant substance (DA-9601) significantly attenuates the severity of oesophageal inflammation in a rat model of oesophagitis (see page 364). Furthermore, they demonstrated that DA-9601 was more effective in the prevention of oesophagitis than physiological concentrations of ranitidine.2
However, before we start prescribing antioxidants for
gastro-oesophageal reflux disease, several factors need to be
considered. Firstly, it is not clear why the authors chose to compare
antioxidants with H2 antagonists rather than with proton
pump inhibitors. Large randomised controlled trials of oesophagitis
suggest that whereas after eight weeks of treatment H2
antagonists achieve complete healing in up to 60% of patients, proton
pump inhibitors achieve endoscopically proved healing in approximately
90% of
Relevant Article
- Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats
- T Y Oh, J S Lee, B O Ahn, H Cho, W B Kim, Y B Kim, Y J Surh, S W Cho, K M Lee, and K B Hahm
Gut 2001 49: 364-371.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
